am A

2 trials

Sponsors

Maruyama Shoichi

Conditions

Chronic kidney disease Chronic kidney disease, metabolic acidosisDiabetes Mellitus, Type 2 Diabetes Mellitus, Type 2

Unknown Phase

RecruitingJPRN-jRCTs041200069

Maruyama ShoichiDiabetes Mellitus, Type 2 Diabetes Mellitus, Type 2

Start: 2020-12-23Target: 110Updated: 2026-06-29

A randomized controlled trial to verify renoprotective effects by alkali treatment with Uralyt combination tablets in patients with chronic kidney disease and metabolic acidosis

RecruitingJPRN-jRCTs041240053

Maruyama ShoichiChronic kidney disease Chronic kidney disease, metabolic acidosis

Start: 2024-07-01Target: 100Updated: 2026-06-29

Related Papers

#412 Influence of SGLT2I on tubulointerstitium in DKD patients with moderate renal dysfunction

Nephrology Dialysis Transplantation2024-05-01

Rationale and study design of a randomized controlled trial to investigate the renoprotective effect of canagliflozin assessed by test of renal hemodynamics in diabetic kidney disease (the FAGOTTO study).

2023-08-031 citations